HYDI Hydromer Inc.

Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors

Hydromer, Inc. Announces Resignation of Board Members and Appointment of New Directors

CONCORD, NC, Aug. 07, 2023 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) today announced the resignation of all its board of directors. There were no disagreements between the Company and the board of directors. The company has swiftly acted to ensure continuity and has appointed new members to its board of directors.

The new appointees to the board include Braeden Lichti of BWL Investments Ltd., George Kovalyov, and Mike Torti, the current CEO of Hydromer, Inc.

Braeden Lichti, who is taking on the role of Chairman, expressed gratitude to the departing board members for their contributions to the company. He stated, "We are looking forward to a renewed phase of growth and innovation at Hydromer. Our new team is committed to delivering value for our shareholders."

Shareholders can anticipate further communication in the coming days. Chairman Braeden Lichti will be providing a n update to all stakeholders.

For further information, please contact Hydromer, Inc.'s corporate communications department.

About Hydromer®

Hydromer®, Inc & Subsidiary (the “Company”) is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer research & development, and manufacturing services capabilities for a wide variety of applications. We are a U.S. public corporation domiciled in Concord, NC. Our customers are located across the United States of America, Europe, and Asia-Pacific. The Company was established in 1980, originally incorporated in the State of New Jersey. We are a U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 production facility. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets, in a wide range of industries. We manage numerous global B2B services such as, coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and secured many patents worldwide at separate times throughout our history including, anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic and thromboresistant coatings.

Contact:

Hydromer Inc.

Michael E. Torti

1-800-326-5976



EN
08/08/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hydromer Inc.

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Thi...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 CONCORD, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended September 30, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-end ...

 PRESS RELEASE

Hydromer, Inc. Announces the Restructuring and Formation of World-Clas...

Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development ·       Company introduces a top-tier team of chemists to lead innovation in hydrophilic coatings and develop cutting-edge, environmentally friendly solutions ·       Restructured R&D division, under new leadership, aims to enhance product offerings, improve operational efficiency, and drive future growth CONCORD, N.C. , Oct. 21, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI), a leader in hydrophilic coating technologie...

 PRESS RELEASE

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Fin...

Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update CONCORD, NC, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain Corporate Highlights and preliminary, unaudited management-prepared financial results for the quarter ended June 30, 2024. These results are based on the most current information available to management, are unaudited and are subject to ch...

 PRESS RELEASE

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Fir...

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 CONCORD, NC, April 29, 2024 (GLOBE NEWSWIRE) -- via -- Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices for over 44 years, is pleased to announce certain preliminary, unaudited management-prepared financial results for the quarter ended March 31, 2024. These results are based on the most current information available to management, are unaudited, and are subject to the completion of the Company’s 2024 year-en...

 PRESS RELEASE

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Co...

Hydromer, Inc. Wraps Up a Successful 2023, Including Restructuring, Contract Extensions, and the Launch of New Innovations CONCORD, NC, Jan. 16, 2024 (GLOBE NEWSWIRE) -- via – Hydromer, Inc. (OTC: HYDI) Hydromer, Inc. (the “Company”) is pleased to provide the following update to shareholders regarding the Company’s progress toward stability and profitable growth. Much has been done since the spring of 2023 in reducing the Company’s overhead and operating costs, which management believes will lead to improved profitability in the current fiscal year. Additionally, investment in new prod...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch